サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676104

獣医腫瘍学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Veterinary Oncology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 140 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
獣医腫瘍学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 140 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

獣医腫瘍学の世界市場規模は、2024年の7億5,000万米ドルから2033年には21億3,000万米ドルに成長し、2026～2033年の予測期間中に12.22％の堅調な年間平均成長率（CAGR）を示すと予測されます。

獣医腫瘍学市場は、ペットの健康に対する認識と動物におけるがんの有病率が上昇し続けていることから、力強い成長を遂げています。ペットの飼い主が最愛の家族のために先進的治療法を求めるようになり、獣医腫瘍学のサービスや製品に対する需要が拡大しています。ペットの健康への関心の高まりは、獣医療の進歩と相まって、動物のがん治療のための革新的な治療法や診断ツールの開発を促進しています。動物病院が腫瘍患者のための専門的治療を優先するようになり、獣医腫瘍学市場の繁栄が予想されます。

技術の進歩は、獣医腫瘍学市場の将来を形作る上で重要な役割を果たしています。MRIやCTスキャンなどの画像診断の技術革新は、ペットの腫瘍を検出・モニタリングする能力を高め、より早く正確な診断につながっています。さらに、標的療法や免疫療法の開発は、獣医療におけるがん治療に革命をもたらし、飼い主により効果的で侵襲の少ない選択肢を提供しています。製造業者と獣医の専門家が研究開発で協力し続けるにつれて、獣医腫瘍学市場は先進的な治療様式と技術の採用が増加すると考えられます。

さらに、個別化医療やホリスティックなペットケアへの取り組みが重視されるようになり、獣医腫瘍学市場に影響を与えています。飼い主がペットの健康について知識を深めるにつれ、個々の患者のニーズや好みを考慮したオーダーメイドの治療計画に対する需要が高まっています。この動向は、従来の治療と栄養や疼痛管理などの補完療法を組み合わせた統合腫瘍学サービスの開発を促進しています。市場が進化を続ける中、技術、個別化ケア、ホリスティック・アプローチの統合は、獣医腫瘍学セグメントにおける成功の重要な促進要因となると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために、細心の注意を払って作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 獣医腫瘍学産業の分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 獣医腫瘍学の世界市場分析：動物タイプ別

  • 動物タイプ別概要
  • 動物タイプ別過去・予測データ分析
  • コンパニオンアニマル（ウマ、イヌ、ネコ）
  • 畜産動物

第6章 獣医腫瘍学の世界市場分析：治療タイプ別

  • 治療タイプ別概要
  • 治療タイプ別過去・予測データ分析
  • 化学療法
  • 併用療法
  • 免疫療法
  • 標的療法

第7章 獣医腫瘍学の世界市場分析：投与形態別

  • 投与形態別概要
  • 投与形態別過去・予測データ分析
  • 経口
  • 静脈内投与

第8章 獣医腫瘍学の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 犬リンパ腫
  • 骨肉腫（OSA）
  • 肥満細胞腫
  • 黒色腫
  • その他

第9章 獣医腫瘍学の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • 政府機関
  • 小売薬局

第10章 獣医腫瘍学の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 獣医腫瘍学企業の競合情勢

  • 獣医腫瘍学市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Zoetis Inc.
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Merck Animal Health
  • Varian Medical Systems
  • Accuray Incorporated
  • PetCure Oncology
  • AB Science
  • Karyopharm Therapeutics Inc.
  • Regeneus Ltd
  • Morphogenesis Inc.
  • VetDC
  • Zenoaq
  • Rhizen Pharmaceutical SA
  • AdvaVet Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Type (USD MN)
  • Companion Animal (Equine, Canine, and Feline) Market Sales By Geography (USD MN)
  • Livestock Animal Market Sales By Geography (USD MN)
  • Analysis By Therapy Type (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Combination Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Analysis By Mode of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Canine Lymphoma Market Sales By Geography (USD MN)
  • Osteosarcoma (OSA) Market Sales By Geography (USD MN)
  • Mast Cell Cancer Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Government Agencies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Veterinary Oncology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Oncology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Type
  • Market Attractiveness Analysis By Therapy Type
  • Market Attractiveness Analysis By Mode of Administration
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Animal Type (USD MN)
  • Companion Animal (Equine, Canine, and Feline) Market Sales By Geography (USD MN)
  • Livestock Animal Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapy Type (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Combination Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Mode of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Canine Lymphoma Market Sales By Geography (USD MN)
  • Osteosarcoma (OSA) Market Sales By Geography (USD MN)
  • Mast Cell Cancer Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Government Agencies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11218350

Global Veterinary Oncology Market size is anticipated to grow from USD 0.75 Billion in 2024 to USD 2.13 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.22% during the forecast period of 2026 to 2033.

The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.

Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Animal Type

  • Companion Animal (Equine, Canine, and Feline)
  • Livestock Animal

By Therapy Type

  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy

By Mode of Administration

  • Oral
  • Intravenous

By Application

  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • COMPANIES PROFILED
  • Zoetis Inc.
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Merck Animal Health
  • Varian Medical Systems
  • Accuray Incorporated
  • PetCure Oncology
  • AB Science
  • Karyopharm Therapeutics Inc.
  • Regeneus Ltd
  • Morphogenesis Inc.
  • VetDC
  • Zenoaq
  • Rhizen Pharmaceutical SA
  • AdvaVet Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VETERINARY ONCOLOGY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Type
    • 3.7.2 Market Attractiveness Analysis By Therapy Type
    • 3.7.3 Market Attractiveness Analysis By Mode of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

  • 5.1. Overview By Animal Type
  • 5.2. Historical and Forecast Data Analysis By Animal Type
  • 5.3. Companion Animal (Equine, Canine, and Feline) Historic and Forecast Sales By Regions
  • 5.4. Livestock Animal Historic and Forecast Sales By Regions

6. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY TYPE

  • 6.1. Overview By Therapy Type
  • 6.2. Historical and Forecast Data Analysis By Therapy Type
  • 6.3. Chemotherapy Historic and Forecast Sales By Regions
  • 6.4. Combination Therapy Historic and Forecast Sales By Regions
  • 6.5. Immunotherapy Historic and Forecast Sales By Regions
  • 6.6. Targeted Therapy Historic and Forecast Sales By Regions

7. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY MODE OF ADMINISTRATION

  • 7.1. Overview By Mode of Administration
  • 7.2. Historical and Forecast Data Analysis By Mode of Administration
  • 7.3. Oral Historic and Forecast Sales By Regions
  • 7.4. Intravenous Historic and Forecast Sales By Regions

8. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data Analysis By Application
  • 8.3. Canine Lymphoma Historic and Forecast Sales By Regions
  • 8.4. Osteosarcoma (OSA) Historic and Forecast Sales By Regions
  • 8.5. Mast Cell Cancer Historic and Forecast Sales By Regions
  • 8.6. Melanoma Historic and Forecast Sales By Regions
  • 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data Analysis By Distribution Channel
  • 9.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 9.4. Government Agencies Historic and Forecast Sales By Regions
  • 9.5. Retail Pharmacies Historic and Forecast Sales By Regions

10. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

  • 11.1. Veterinary Oncology Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Zoetis Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Elanco
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Boehringer Ingelheim International GmbH
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Merck Animal Health
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Varian Medical Systems
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Accuray Incorporated
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. PetCure Oncology
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. AB Science
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Karyopharm Therapeutics Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Regeneus Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Morphogenesis Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. VetDC
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Zenoaq
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Rhizen Pharmaceutical SA
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. AdvaVet Inc
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies